MGX financials
Metagenomi Therapeutics (MGX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- MGX revenue was $25.21M in fiscal 2025, net income -$87.87M.
MGX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $25.21M | – | -$96.01M | -$87.87M | -2.36 |
| 2024 | $52.30M | – | -$88.90M | -$78.06M | -2.36 |
| 2023 | $44.76M | – | -$78.49M | -$68.25M | -20.05 |